External Partnership in Action Award
19 September 2016
The External Partnership in Action Award recognised the partnership between PHE and Dr Hannah Christensen, School of Social and Community Medicine, University of Bristol, which was responsible for the introduction of the Meningitis B vaccine for infants.
New data presented at the International Pathogenic Neisseria Conference shows that meningitis and septicaemia cases caused by Meningococcal group B have nearly halved in eligible infants since the vaccine was introduced in 2015.
MenB is a rare disease but can have devastating consequences and this vaccine saves lives. 37 cases have been recorded in the eligible age group since the programme began; this compares to an average of 74 cases in the same period from the previous 4 years. This is great news and is the world’s first infant programme using this vaccine